China Approves Fifth Domestic PD-1 Drug

Just Misses Out On Annual Price Negotiations

Akeso/Sino Biopharm's pd-1 approval
The addition makes China's domestic pd-1 market even more crowded • Source: Alamy
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from New Products

More from Scrip